Tag Archives: MaRS

RESI on MaRS Panel Announcement: Corporate Venture Capital

2 Mar

By Cole Bunn, Senior Research Analyst, LSN


Large corporations, especially in the pharmaceutical/biotech world, play a very important role in anchoring an innovation ecosystem. The most notable activity of these corporations is perhaps their role as an investor in and buyer of innovation, an exit partner; however, attracting and concentrating talent, providing access to resources and experts are also vital elements of a healthy entrepreneurial community that big pharma brings with its presence. Corporate venture funds, which can serve as a vehicle for big pharma to make riskier/earlier investments, continue to find their way into more and more biotech venture rounds every year.

Toronto, looking to ramp up commercialization of its world-class research and put its name on the map as a life science powerhouse, will host the RESI conference for the second time and welcome a panel of Corporate Venture investors. This increasingly important investor class will discuss trends in the space, their current interests and how entrepreneurs can best prepare to pitch to and work with a group like theirs.

Moderated by John Gustofson, Senior Director, Abbvie Ventures, this panel will feature:

By registering for RESI on MaRS, you’ll be able to listen to the Corporate Venture Capital panel live and learn how to position yourself to work with this type of group as well as interact with the a range of investors and entrepreneurs and experience numerous opportunities to expand your network in the life sciences.

Consumer Health in the Spotlight at RESI on MaRS

23 Feb

By Cole Bunn, Senior Research Analyst, LSN


As we move closer to the second holding of the RESI conference in Toronto at the MaRs Discovery District, we are delighted to make our first panel announcement: Consumer Health Investors.

Desire for greater autonomy in healthcare management/decision-making and healthy lifestyle trends coupled with advances in technology has created investor interest in health solutions that are provided directly to consumers, including the new consumer subsector of digital health. This panel will focus on these investors who are backing technologies that aim to empower consumers to take charge of their health. Given the region’s concentration of these types of startups, Toronto is a fantastic venue for this session exploring the unique opportunities and challenges in this emerging space.

The session will feature the following:

By registering for RESI on MaRS, you’ll be able to listen to the Consumer Health panel live in person, interact with the investors and experience numerous opportunities to expand your network in the life sciences.

Discounted Rates for Hotel and Travel at RESI on MaRS

16 Feb

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-newThe 2017 RESI on MaRS conference is proud to be partnering with hotels and airlines to offer attendees exclusive discounts during their stay in Toronto.

Porter Airlines and Air Canada are both offering discounts on flights to Toronto for flights scheduled from April 1 – 8, 2017. The Fairmount Royal York Hotel is also offering discounts from April 3 – 5, 2017. Additional hotel partners include Sheraton Centre Toronto and Chelsea Hotel.

Included are the promo codes and links to our RESI on MaRS partners and we look forward to seeing you in Toronto.

hotelFairmont Royal York
Address: 100 Front St W, Toronto, ON M5J 1E3, Canada
Phone: +1 416-368-2511
Rate for RESI on MaRS Attendees (Apr. 3 – Apr. 5)

Book Now


Sheraton Centre Toronto
Address: 123 Queen St W, Toronto, ON M5H 2M9, Canada
Phone: +1 416-361-1000

Book Now


Chelsea Hotel
Address: 33 Gerrard St W, Toronto, ON M5G 1Z4, Canada
Phone: +1 416-595-1975

Book Now


porterPorter Airlines is proud to offer a 10% discount on available base fares (with the exception of the lowest class fare during a public seat sale) for travel to and from the MaRS Health Investors Conference. Please book online here or through your travel agent using promo code MARS17. The discounted fares are available for booking from December 22, 2016 to April 8, 2017 and available for travel:


Location: Dates of Travel:
From: Anywhere in Canada or US To: Toronto From: April 1, 2017 To: April 5, 2017
From: Toronto To: Anywhere in Canada or US From: April 4, 2017 To: April 8, 2017

Book Now


Air Canada is pleased to offer 15% off of flex fares for the RESI on MaRS Conference in Toronto. Discounts apply 7 days pre & post conference, simply go to aircanada.com and add the code VDKVFRG1 in the promotion box and the discounts will calculate automatically.

Book Now

RESI on MaRS: Full Agenda Announced

9 Feb

By Michael Quigley, VP of Market Research, LSN


As RESI prepares for its second landing on MaRS on April 4th, the team at Life Science Nation is proud to announce the RESI investor panel agenda. With three tracks of panel and workshop content, RESI will feature a wealth of speakers representing all categories of life science investors, from family offices to VCs and angels to big pharma. These panels are a must-see for any fundraising entrepreneur in the sector.

New to Toronto this year LSN will be bringing our latest and highly popular Asia-North America Panel Track, featuring 15 speakers representing Asia based firms seeking to invest in and/or acquire North American life science companies. Entrepreneurs can hear from real investors who are  driving the increase in transpacific investments. See if your technology fits their mandate!

We are excited to be bringing these diverse investor groups into the flourishing innovation hub of Toronto and granting them a unique look into Canada’s innovative healthcare scene. Stay tuned for updates as we continue to confirm speakers and announce panels.


An Exclusive Look: RESI on MaRS

9 Feb

By Christine A. Wu, Senior Research Analyst, LSN


On April 4th, the Redefining Early Stage Investments (RESI) Conference will be held at the MaRS Discovery District for the second time. RESI is a full day partnering event that allows early-stage life science, med tech, and digital health companies meet and develop relationships with investors and strategic partners all within the heart of Canada’s healthcare innovation hub.

“It was unique in that it allowed us, in a short period of time, to connect with potential investors, potential clients, folks in the ecosystem we already knew, and new folks we wanted to meet.” – Raymond Shih, President & Co-Founder, QOC Health

Due to the success of last year’s conference RESI (500 attendees, facilitating over 800 meetings between companies and potential investors and partners) this year the conference will be held during Toronto’s Health Innovation Week.

Catch a glimpse into the RESI on MaRS Conference in the video below, and be sure to register for RESI@MaRS for a chance to dive straight into Toronto’s Health Innovation scene!

RESI on MaRS – Spotlight Your Technology in the RESI Innovation Challenge

2 Feb

By Shaoyu Chang, MD, MPH, Director of Research & Asia Business Development Liaison, LSN

Shaoyu 10*10

LSN is gearing up for the upcoming Redefining Early Stage Investments (RESI) Conference in Toronto’s MaRS Discovery District, and we’re seeking fundraising CEOs with the most promising early stage healthcare technologies to showcase in the RESI Innovation Challenge on April 4, 2017.

LSN’s scientific team is preparing to review the RESI Innovation Challenge applications from therapeutics, medtech, diagnostics and healthcare IT companies around the globe. All applicants will be vetted based on not only the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.

On April 4, 2017, each attendee will receive “RESI Cash” to allocate to the entrepreneurs whose technologies they expect will be most influential. The capital invested will be tallied up and the top three winners will receive prizes and be featured in our RESI newsletter recap that will go out to LSN’s 20,000 newsletter readership. See below for the previous RESI Innovation Challenge first place winners – a diverse group of startups from every area of the life sciences.

What makes the RESI Innovation Challenge so valuable?  We’ve included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI. Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity.



Here is what our previous winners are saying about the RESI Innovation Challenge:


“It was an absolute pleasure to participate in the RESI conference held at MaRS in Toronto. The unique structure of the conference facilitated creating new relationships with potential investors and partners. In particular, the Innovation Challenge pushed us to introduce ourselves to new people, which will be useful as we look towards a future financing round. I definitely recommend the RESI conferences to entrepreneurs seeking financing in the bio / health space.”
– Raymond Shih, President, Co-Founder, QoC Health
3rd Place, RESI on MaRS, June 23, 2016

“I love the RESI Innovation Challenge because it is a great way to give our pitch to practice it and try to obtain a scarce resource from these investors. Practicing with these investors is a great way to build relationships and continue that on to the real investment conversations.”

– Niko Skievaski, Co-Founder, Redox

1st Place, RESI@TMCx, June 8, 2015


“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space.  It’s a good showcase to reach that audience.”

– Jessica Ching, CEO, Eve Medical

2nd Place, RESI San Francisco, January 12, 2016

“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”

– John Connolly, VP Corporate Development, Rna Diagnostics

1st Place, RESI Boston, September 16, 2015


“RESI offers small companies like GeneSegues a direct line to potential partners and potential investors in a small setting conducive to relationship building and conversation. The Innovation Challenge was a particularly great way to introduce our company to a broader audience than I could meet with personally which allowed us to leverage the showcasing of our technology more efficiently.”

-Laura M. Brod,Chief Executive Officer,GeneSegues Therapeutics

-1st Place, RESI @TMCx, April 11, 2016

RESI Lands on MaRS Again in 2017

19 Jan

Natasha Eldridge, Marketing Manager – RESI Conference Series, LSN

On April 4, 2017, The Redefining Early Stage Investments (RESI) Conference will be back to Toronto’s MaRS Discovery District, the home of notable life science organizations including JLABS@Toronto, the Ontario Institute for Cancer Research, Synaptive Medical, and LEAGUE. RESI on MaRS will bring together fundraising CEOs and early stage investors from around the globe, providing the opportunity for dialogue and relationship building, with the goal of eventual capital allocations.

What to expect numbers

Don’t miss the opportunity to attend the 12th RESI conference where you will speak one-on-one with active investors, establish strategic partnerships, learn from the 20 in-depth panels featuring investors across 10 categories (Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, Venture Capital and more) and find collaborators for licensing and research.

%d bloggers like this: